TPA
Trivium Point Advisory’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.94M | Buy |
10,453
+899
| +9% | +$167K | 0.21% | 120 |
|
|
2025
Q1 | $2M | Buy |
9,554
+341
| +4% | +$71.4K | 0.25% | 112 |
|
|
2024
Q4 | $1.64M | Sell |
9,213
-20
| -0.2% | -$3.55K | 0.21% | 123 |
|
|
2024
Q3 | $1.57M | Sell |
9,233
-1,772
| -16% | -$302K | 0.22% | 123 |
|
|
2024
Q2 | $1.89M | Buy |
11,005
+4,317
| +65% | +$740K | 0.28% | 104 |
|
|
2024
Q1 | $1.22M | Sell |
6,688
-129
| -2% | -$23.5K | 0.26% | 100 |
|
|
2023
Q4 | $1.06M | Buy |
6,817
+120
| +2% | +$18.6K | 0.26% | 105 |
|
|
2023
Q3 | $987K | Buy |
6,697
+443
| +7% | +$65.3K | 0.27% | 109 |
|
|
2023
Q2 | $843K | Buy |
6,254
+112
| +2% | +$15.1K | 0.23% | 122 |
|
|
2023
Q1 | $979K | Buy |
6,142
+4,363
| +245% | +$695K | 0.26% | 118 |
|
|
2022
Q4 | $296K | Sell |
1,779
-2
| -0.1% | -$333 | 0.09% | 158 |
|
|
2022
Q3 | $250K | Sell |
1,781
-224
| -11% | -$31.4K | 0.08% | 163 |
|
|
2022
Q2 | $305K | Sell |
2,005
-1,842
| -48% | -$280K | 0.09% | 166 |
|
|
2022
Q1 | $650K | Buy |
3,847
+503
| +15% | +$85K | 0.14% | 152 |
|
|
2021
Q4 | $453K | Buy |
3,344
+499
| +18% | +$67.6K | 0.1% | 172 |
|
|
2021
Q3 | $315K | Buy |
2,845
+109
| +4% | +$12.1K | 0.07% | 180 |
|
|
2021
Q2 | $308K | Buy |
+2,736
| New | +$308K | 0.08% | 182 |
|